
QV Bioelectronics awarded £1.26M to advance studies on new brain cancer treatment
QV Bioelectronics, developer of an implanted Electric Field Therapy (EFT) device for brain tumours, has announced it has been awarded a 1.26 million GBP grant under the Biomedical Catalyst programme. The funding will support key technical and regulatory …